CR9288A - Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas - Google Patents
Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadasInfo
- Publication number
- CR9288A CR9288A CR9288A CR9288A CR9288A CR 9288 A CR9288 A CR 9288A CR 9288 A CR9288 A CR 9288A CR 9288 A CR9288 A CR 9288A CR 9288 A CR9288 A CR 9288A
- Authority
- CR
- Costa Rica
- Prior art keywords
- cells
- immunoprotection
- transplanted neural
- medula
- osea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invencion comprende metodos y composiciones para reducir una respuesta inmune a un recipiente del trasplante que recibe las NSC mediante el tratamiento de dicho recipiente con una cantidad de medula osea estromal efectiva para reducir o inhibir el rechazo por el hospedero de las NSC.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64343605P | 2005-01-11 | 2005-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9288A true CR9288A (es) | 2008-01-15 |
Family
ID=36677954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9288A CR9288A (es) | 2005-01-11 | 2007-08-06 | Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060153819A1 (es) |
EP (1) | EP1841322A4 (es) |
JP (1) | JP2008526891A (es) |
KR (1) | KR20070100351A (es) |
CN (1) | CN101137292A (es) |
AU (1) | AU2006205033A1 (es) |
BR (1) | BRPI0606678A2 (es) |
CA (1) | CA2593668A1 (es) |
CR (1) | CR9288A (es) |
IL (1) | IL184470A0 (es) |
MX (1) | MX2007008437A (es) |
RU (1) | RU2007130695A (es) |
WO (1) | WO2006076374A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010117464A1 (en) * | 2009-04-09 | 2010-10-14 | Sangamo Biosciences, Inc. | Targeted integration into stem cells |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
WO1999046366A1 (en) * | 1998-03-13 | 1999-09-16 | Osiris Therapeutics, Inc. | Uses for humane non-autologous mesenchymal stem cells |
DE69929681T2 (de) * | 1998-03-18 | 2006-10-26 | Osiris Therapeutics, Inc. | Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen |
US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
AU6276899A (en) * | 1998-09-29 | 2000-04-17 | Diacrin, Inc. | Transplantation of neural cells for the treatment of ischemic damage due to stroke |
US20050169896A1 (en) * | 1999-05-14 | 2005-08-04 | Henry Ford Health System | Bone marrow transplantation for treatment of stroke |
WO2001076507A2 (en) * | 2000-04-11 | 2001-10-18 | The University Of Miami | Use of oxygen carriers to improve grafted cell survival in neural transplantation |
GB2386125B (en) * | 2000-11-22 | 2005-02-23 | Geron Corp | Tolerizing allografts of pluripotent stem cells |
-
2006
- 2006-01-10 CN CNA2006800079375A patent/CN101137292A/zh active Pending
- 2006-01-10 JP JP2007550564A patent/JP2008526891A/ja active Pending
- 2006-01-10 WO PCT/US2006/000839 patent/WO2006076374A1/en active Application Filing
- 2006-01-10 CA CA002593668A patent/CA2593668A1/en not_active Abandoned
- 2006-01-10 BR BRPI0606678-0A patent/BRPI0606678A2/pt not_active IP Right Cessation
- 2006-01-10 KR KR1020077018252A patent/KR20070100351A/ko not_active Application Discontinuation
- 2006-01-10 EP EP06717972A patent/EP1841322A4/en not_active Withdrawn
- 2006-01-10 AU AU2006205033A patent/AU2006205033A1/en not_active Abandoned
- 2006-01-10 RU RU2007130695/14A patent/RU2007130695A/ru not_active Application Discontinuation
- 2006-01-10 MX MX2007008437A patent/MX2007008437A/es unknown
- 2006-01-10 US US11/328,976 patent/US20060153819A1/en not_active Abandoned
-
2007
- 2007-07-08 IL IL184470A patent/IL184470A0/en unknown
- 2007-08-06 CR CR9288A patent/CR9288A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2007130695A (ru) | 2009-02-20 |
EP1841322A1 (en) | 2007-10-10 |
WO2006076374A1 (en) | 2006-07-20 |
AU2006205033A1 (en) | 2006-07-20 |
CA2593668A1 (en) | 2006-07-20 |
IL184470A0 (en) | 2007-10-31 |
BRPI0606678A2 (pt) | 2009-07-07 |
CN101137292A (zh) | 2008-03-05 |
MX2007008437A (es) | 2008-02-19 |
EP1841322A4 (en) | 2009-12-09 |
JP2008526891A (ja) | 2008-07-24 |
US20060153819A1 (en) | 2006-07-13 |
KR20070100351A (ko) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2016000107A (es) | PIRROLO[1,2-f][1,2,4]TRIAZINAS ÚTILES PARA TRATAR INFECCIONES POR EL VIRUS SINCITIAL RESPIRATORIO. | |
AR054465A1 (es) | Concentrado para suspender en aceites | |
CL2017001686A1 (es) | 5-fluoro-4-imino-3-(alquil/alquil sustituido)-1-(arilsulfonil)-3,4-dihidropirimidin-2(1h)-ona como tratamiento de semillas. | |
CR20130175A (es) | Métodos y composiciones que contienen jasmonato o compuestos relacionados para promover la actividad de biodefensa en las plantas | |
CL2017000893A1 (es) | Composición que comprende un agente de control biológico de la especie bacillus subtilis y un fungicida seleccionado de protioconazol, espiroxamina, y tebuconazol; uso de la composición, procedimiento que la utiliza; y un kit que la contiene. | |
AR089596A1 (es) | Cepas de bradyrhizobium | |
GT201000029A (es) | Composiciones y metodos para controlar nematodos | |
ECSP11011310A (es) | Análogos carba - nucleósido para tratamiento antiviral | |
CR10136A (es) | Nucleósidos antivirales | |
CL2011002116A1 (es) | Compuestos derivados de acetamida sustituida por n-heteroaril o 2-heteroaril como moduladores de las señales wnt; composiciones farmaceuticas que los comprenden; y su uso en el tratamiento del cancer, rechazo de injerto de riñon, osteoartritis, parkinson, entre otras. | |
CL2009001476A1 (es) | Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular. | |
BR112017011422A2 (pt) | compostos de ácido isoazol hidro¬xâmico como inibidores de lpxc | |
AR062227A1 (es) | Metodo para mejorar el crecimiento de las plantas reduciendo las infecciones viricas | |
CR11453A (es) | Compuestos nucleosidos antivirales | |
ECSP20084373A (es) | Tiofencarboxamidas sustituidas y análogos de las mismas | |
CO6511234A2 (es) | Métodos de multiplicación vegetativa de plantas herbáceas | |
EA201890314A3 (ru) | Композиции, содержащие липохитоолигосахарид и микроорганизм для усиления роста растения | |
CL2017001903A1 (es) | Composición novedosa para uso en el incremento de eficacia de injerto de células madre hematopoyéticas después del trasplante | |
AR086326A1 (es) | Metodo para promover el crecimiento de plantas | |
UY30896A1 (es) | Composicion fitosanitaria | |
CL2017002320A1 (es) | Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición | |
AR046729A1 (es) | Concentrado de tienil-sulfonamidas para suspender en aceites | |
CR9288A (es) | Celulas estromales de medula osea para la inmunoproteccion de celulas madre neurales transplantadas | |
PE20151248A1 (es) | Derivados de ciclopentano como inhibidores de catepsinas | |
CR20110589A (es) | Compuestos y métodos para controlar hongos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |